Alterations in mRNA expression and protein products following spinal cord injury in humans

Journal of Physiology

Volumn 579, Issue 3, 2007, Pages 877-892

  Urso, Maria L ^a,c   Chen, Yi Wen ^b   Scrimgeour, Angus G ^c   Lee, Patrick C ^d   Lee, K Francis ^d   Clarkson, Priscilla M ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c U S ARMY RESEARCH INSTITUTE OF ENVIRONMENTAL MEDICINE   (United States)

^d BAYSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROGIN 1; MESSENGER RNA; METALLOTHIONEIN I; METALLOTHIONEIN IA; METALLOTHIONEIN IF; METALLOTHIONEIN IH; MUSCLE PROTEIN; MUSCLE SPECIFIC RING FINGER PROTEIN 1; PROTEASOME; PROTEASOME SUBUNIT 11; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; UBIQUITIN PROTEIN E3 LIGASE C; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; MUSCLE ATROPHY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEINASE INHIBITION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; SPINAL CORD INJURY; UBIQUITINATION; WESTERN BLOTTING; ENZYME INHIBITION; GENE; MAFBX GENE; MT1A GENE; MT1F GENE; MT1H GENE; MURF1 GENE; PSMD11 GENE; REAL TIME POLYMERASE CHAIN REACTION; SLPI GENE; UBE3C GENE;

ADULT; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; METALLOTHIONEIN; MIDDLE AGED; MUSCLE FIBERS; MUSCLE, SKELETAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEASOME ENDOPEPTIDASE COMPLEX; RNA, MESSENGER; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; SPINAL CORD INJURIES; UBIQUITIN;

EID: 33947097911     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2006.118042     Document Type: Article

References (47)

1. Apostolova MD, Ivanova IA & Cherian MG (1999). Metallothionein and apoptosis during differentiation of myoblasts to myotubes: Protection against free radical toxicity. Toxicol Appl Pharmacol 159, 175-184.
2. Attaix D, Aurousseau E, Combaret L, Kee A, Larbaud D, Ralliere C, Souweine B, Taillandier D & Tilignac T (1998). Ubiquitin-proteasome-dependent proteolysis in skeletal muscle. Reprod Nutr Dev 38, 153-165.
3. Bassaglia Y, Cebrian J, Covan S, Garcia M & Foucrier J (2005). Proteasomes are tightly associated to myofibrils in mature skeletal muscle. Exp Cell Res 302, 221-232.
4. Batt J, Bain J, Goncalves J, Michalski B, Plant P, Fahnestock M & Woodgett J (2006). Differential gene expression profiling of short and long term denervated muscle. FASEB J 20, 115-117.
5. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, Pan ZQ, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD & Glass DJ (2001). Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294, 1704-1708.
6. Booth FW & Gollnick PD (1983). Effects of disuse on the structure and function of skeletal muscle. Med Sci Sports Exerc 15, 415-420.
7. Chen YW, Hubal MJ, Hoffman EP, Thompson PD & Clarkson PM (2003). Molecular responses of human muscle to eccentric exercise. J Appl Physiol 95, 2485-2494.
8. Chen YW, Nagaraju K, Bakay M, McIntyre O, Rawat R, Shi R & Hoffman EP (2005). Early onset of inflammation and later involvement of TGFα in Duchenne muscular dystrophy. Neurology 65, 826-834.
9. Chen YW, Zhao P, Borup R & Hoffman EP (2000). Expression profiling in the muscular dystrophies: Identification of novel aspects of molecular pathophysiology. J Cell Biol 151, 1321-1336.
10. DeJong CH, Busquets S, Moses AG, Schrauwen P, Ross JA, Argiles JM & Fearon KC (2005). Systemic inflammation correlates with increased expression of skeletal muscle ubiquitin but not uncoupling proteins in cancer cachexia. Oncol Rep 14, 257-263.
11. Di Giovanni S, Molon A, Broccolini A, Melcon G, Mirabella M, Hoffman EP & Servidei S (2004). Constitutive activation of MAPK cascade in acute quadriplegic myopathy. Ann Neurol 55, 195-206.
12. Dudley GA, Castro MJ, Rogers S & Apple DF Jr (1999). A simple means of increasing muscle size after spinal cord injury: A pilot study. Eur J Appl Physiol Occup Physiol 80, 394-396.
13. Dupont-Versteegden EE, Houle JD, Gurley CM & Peterson CA (1998). Early changes in muscle fiber size and gene expression in response to spinal cord transection and exercise. Am J Physiol Cell Physiol 275, C1124-C1133.
14. Goldspink DF (1976). The effects of denervation on protein turnover of rat skeletal muscle. Biochem J 156, 71-80.
15. Gomes MD, Lecker SH, Jagoe RT, Navon A & Goldberg AL (2001). Atrogin -1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci U S A 98, 14440-14445.
16. Hoffman EPAT, Palma J, Webster T, Hubbell E, Warrington JA, Spira A, Wright G, Buckley J, Triche T, Davis R, Tibshirani R, Xaio W, Jones W, Tomkins R & West M (2004). Expression profiling -best practices for data generation and interpretation in clinical trials. Nat Rev Genet 5, 229-237.
17. Hornberger TA, Hunter RB, Kandarian SC & Esser KA (2001). Regulation of translation factors during hindlimb unloading and denervation of skeletal muscle in rats. Am J Physiol Cell Physiol 281, C179-C187.
18. Ikemoto M, Nikawa T, Takeda S, Watanabe C, Kitano T, Baldwin KM, Izumi R, Nonaka I, Towatari T, Teshima S, Rokutan K & Kishi K (2001). Space shuttle flight (STS-90) enhances degradation of rat myosin heavy chain in association with activation of ubiquitin-proteasome pathway. FASEB J 15, 1279-1281.
19. Jagoe RT, Lecker SH, Gomes M & Goldberg AL (2002). Patterns of gene expression in atrophying skeletal muscles: Response to food deprivation. FASEB J 16, 1697-1712.
20. Jones SW, Hill RJ, Krasney PA, O'Conner B, Peirce N & Greenhaff PL (2004). Disuse atrophy and exercise rehabilitation in humans profoundly affects the expression of genes associated with the regulation of skeletal muscle mass. FASEB J 18, 1025-1027.
21. Khal J, Hine AV, Fearon KC, Dejong CH & Tisdale MJ (2005). Increased expression of proteasome subunits in skeletal muscle of cancer patients with weight loss. Int J Biochem Cell Biol 37, 2196-2206.
22. Kjaer M (2004). Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. Physiol Rev 84, 649-698.
23. Kondo H, Miura M, Nakagaki I, Sasaki S & Itokawa Y (1992). Trace element movement and oxidative stress in skeletal muscle atrophied by immobilization. Am J Physiol Endocrinol Metab 262, E583-E590.
24. Krawiec BJ, Frost RA, Vary TC, Jefferson LS & Lang CH (2005). Hindlimb casting decreases muscle mass in part by proteasome-dependent proteolysis but independent of protein synthesis. Am J Physiol Endocrinol Metab 289, E969-E980.
25. Kumamoto T, Fujimoto S, Ito T, Horinouchi H, Ueyama H & Tsuda T (2000). Proteasome expression in the skeletal muscles of patients with muscular dystrophy. Acta Neuropathol 100, 595-602.
26. Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J, Price SR, Mitch WE & Goldberg AL (2004). Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 18, 39-51.
27. Léger BVL, SorarùG, Hespel P, Derave W, Goblet C, D'Ascenzio C, Angelini C & Russell AP (2006). Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1. FASEB J 20, 583-585.
28. Li C & Hung Wong W (2001). Model-based analysis of oligonucleotide arrays: Model validation, design issues, and standard error application. Genome Biol 8, 32.31-32.32.11.
29. Li HH, Kedar V, Zhang C, McDonough H, Arya R, Wang DZ & Patterson C (2004). Atrogin -1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. J Clin Invest 114, 1058-1071.
30. Lin AL, Johnson DA, Stephan KT & Yeh CK (2004). Salivary secretory leukocyte protease inhibitor increases in HIV infection. J Oral Pathol Med 33, 410-416.
31. Ma G, Greenwell-Wild T, Lei K, Jin W, Swisher J, Hardegen N, Wild CT & Wahl SM (2004). Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection. J Exp Med 200, 1337-1346.
32. Mahoney DJ, Carey K, Fu MH, Snow R, Cameron-Smith D, Parise G & Tarnopolsky MA (2004). Real-time RT-PCR analysis of housekeeping genes in human skeletal muscle following acute exercise. Physiol Genomics 18, 226-231.
33. Medina R, Wing SS, Haas A & Goldberg AL (1991). Activation of the ubiquitin-ATP-dependent proteolytic system in skeletal muscle during fasting and denervation atrophy. Biomed Biochim Acta 50, 347-356.
34. Mitch WE, Bailey JL, Wang X, Jurkovitz C, Newby D & Price SR (1999). Evaluation of signals activating ubiquitinproteasome proteolysis in a model of muscle wasting. Am J Physiol Cell Physiol 276, C1132-C1138.
35. Nikawa T, Ishidoh K, Hirasaka K, Ishihara I, Ikemoto M, Kano M, Kominami E, Nonaka I, Ogawa T, Adams GR, Baldwin KM, Yasui N, Kishi K & Takeda S (2004). Skeletal muscle gene expression in space-flown rats. FASEB J 18, 522-524.
36. Penkowa M, Keller P, Keller C, Hidalgo J, Giralt M & Pedersen BK (2005). Exercise-induced metallothionein expression in human skeletal muscle fibres. Exp Physiol 90, 477-486.
37. Raffaello A, Laveder P, Romualdi C, Bean C, Toniolo L, Germinario E, Megighian A, Danieli-Betto D, Reggiani C & Lanfranchi G (2006). Denervation in murine fast-twitch muscle: Short term physiological changes and temporal expression profiling. Physiol Genomics 25, 60-74.
38. Schadt EE, Li C, Ellis B & Wong WH (2001). Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data. J Cell Biochem Suppl 37, 120-125.
39. Scheede-Bergdahl C, Penkowa M, Hidalgo J, Olsen DB, Schjerling P, Prats C, Boushel R & Dela F (2005). Metallothionein-mediated antioxidant defense system and its response to exercise training are impaired in human type 2 diabetes. Diabetes 54, 3089-3094.
40. Sehnert B, Cavcic A, Bohm B, Kalden JR, Nandakumar KS, Holmdahl R & Burkhardt H (2004). Antileukoproteinase: Modulation of neutrophil function and therapeutic effects on anti-type II collagen antibody-induced arthritis. Arthritis Rheum 50, 2347-2359.
41. Sevetson BRKX & Lawrence JC (1993). Increasing cAMP attenuates activation of mitogen-activated protein kinase. Proc Natl Acad Sci U S A 90, 10305-10309.
42. Taillandier D, Aurousseau E, Combaret L, Guezennec CY & Attaix D (2003). Regulation of proteolysis during reloading of the unweighted soleus muscle. Int J Biochem Cell Biol 35, 665-675.
43. Taillandier D, Combaret L, Pouch MN, Samuels SE, Bechet D & Attaix D (2004). The role of ubiquitin-proteasome-dependent proteolysis in the remodelling of skeletal muscle. Proc Nutr Soc 63, 357-361.
44. Tang H, Cheung WM, Ip FC & Ip NY (2000). Identification and characterization of differentially expressed genes in denervated muscle. Mol Cell Neurosci 16, 127-140.
45. Urso ML, Scrimgeour A, Chen YW, Thompson PD & Clarkson PM (2006). Analysis of mRNA and protein in human skeletal muscle after 48h immobilization. J Appl Physiol 101, 1136-1148.
46. Welle S, Brooks AI, Delehanty JM, Needler N & Thornton CA (2003). Gene expression profile of aging in human muscle. Physiol Genomics 14, 149-159.
47. Whitman SA, Wacker MJ, Richmond SR & Godard MP (2005). Contributions of the ubiquitin-proteasome pathway and apoptosis to human skeletal muscle wasting with age. Pflugers Arch 450, 437-446.